The popularity of Viagra initially fueled a boom for major pharmaceutical companies, nevertheless recent developments present a uncertain outlook for shareholders. Off-patent alternatives are eroding revenue, and https://jessexpfd975635.estate-blog.com/40012495/the-blue-pill-and-the-pharmaceutical-industry-a-precarious-play